Lilly Gets Longer Reprieve On Strattera Appeal
A federal appeals court has extended a temporary hold on the generic-drug makers seeking to launch their own versions of Eli Lilly & Co.'s attention deficit/hyperactivity disorder drug Strattera....To view the full article, register now.
Already a subscriber? Click here to view full article